Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12864420 | 0.96 | PDK2 (0.33) | PDK2KDM4EALDH1A1L3MBTL1HPRT1 | |
| SCHEMBL2606146 | 0.96 | PDK2 (0.35) | PDK2KDM4EALDH1A1L3MBTL1HPRT1 | |
| SCHEMBL2606001 | 0.92 | PDK2 (0.34) | PDK2KDM4EALDH1A1L3MBTL1HPRT1 | |
| SCHEMBL2606055 | 0.92 | PDK2 (0.39) | PDK2KDM4EALDH1A1L3MBTL1 | |
| SCHEMBL10054080 | 0.88 | KDM4E (0.33) | PDK2KDM4EALDH1A1L3MBTL1 | |
| SCHEMBL12864426 | 0.86 | PDK2 (0.32) | PDK2KDM4EALDH1A1L3MBTL1 | |
| SCHEMBL2606149 | 0.85 | KDM4E (0.38) | PDK2KDM4EALDH1A1L3MBTL1 | |
| SCHEMBL12864359 | 0.84 | PDK2 (0.38) | PDK2KDM4EALDH1A1L3MBTL1 | |
| SCHEMBL11927557 | 0.83 | PDK2 (0.37) | PDK2KDM4EALDH1A1L3MBTL1HPRT1 | |
| SCHEMBL12864350 | 0.83 | KDM4E (0.33) | PDK2KDM4EALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023117835-A1 | ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-06-29 | — | — | WO | disclosed |
| US-8361638-B2 | Fluorine derivatives for organic electroluminescence devices | MERCK PATENT GMBH (DE) | 2013-01-29 | — | — | US | disclosed |
| EP-2260023-B1 | FLUORENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2012-04-25 | — | — | EP | disclosed |
| US-20110037027-A1 | FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2011-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110037027-A1 | FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES | SLCO4C1, CTCF, AFF2 | PDK2 2382/4885KDM4E 1747/4885ALDH1A1 2171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.